{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:13:08Z","timestamp":1792800788282,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PRIN2020","award":["CW39SJ"],"award-info":[{"award-number":["CW39SJ"]}]},{"name":"ANTHEM","award":["CUPB53C22006540001"],"award-info":[{"award-number":["CUPB53C22006540001"]}],"id":[{"id":"https:\/\/ror.org\/01geb0342","id-type":"ROR","asserted-by":"crossref"}]},{"name":"PNRR","award":["M6\/C2"],"award-info":[{"award-number":["M6\/C2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer cells are characterized by uncontrolled cell proliferation and impaired bioenergetics. Sirtuins are a family of highly conserved enzymes that play a fundamental role in energy metabolism regulation. SIRT1, in particular, drives many physiological stress responses and metabolic pathways following nutrient deprivation. We previously showed that SIRT1 activation using SCIC2.1 was able to attenuate genotoxic response and senescence. Here, we report that in hepatocellular carcinoma (HCC) cells under glucose-deprived conditions, SCIC2.1 treatment induced overexpression of SIRT1, SIRT3, and SIRT6, modulating metabolic response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Flow cytometry was used to analyze the cell cycle. The MTT assay and xCELLigence system were used to measure cell viability and proliferation. In vitro enzymatic assays were carried out as directed by the manufacturer, and the absorbance was measured with an automated Infinite M1000 reader. Western blotting and immunoprecipitation were used to evaluate the expression of various proteins described in this study. The relative expression of genes was studied using real-time PCR. We employed a Seahorse XF24 Analyzer to determine the metabolic state of the cells. Oil Red O staining was used to measure lipid accumulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SCIC2.1 significantly promoted mitochondrial biogenesis via the AMPK-p53-PGC1\u03b1 pathway and enhanced mitochondrial ATP production under glucose deprivation. SIRT1 inhibition by Ex-527 further supported our hypothesis that metabolic effects are dependent on SIRT1 activation. Interestingly, SCIC2.1 reprogrammed glucose metabolism and fatty acid oxidation for bioenergetic circuits by repressing de novo lipogenesis. In addition, SCIC2.1-mediated SIRT1 activation strongly modulated antioxidant response through SIRT3 activation, and p53-dependent stress response via indirect recruitment of SIRT6.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our results show that SCIC2.1 is able to promote energy homeostasis, attenuating metabolic stress under glucose deprivation via activation of SIRT1. These findings shed light on the metabolic action of SIRT1 in the pathogenesis of HCC and may help determine future therapies for this and, possibly, other metabolic diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04440-9","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T16:28:51Z","timestamp":1694795331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism"],"prefix":"10.1186","volume":"21","author":[{"given":"Benluvankar","family":"Varghese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Chianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Capasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Sian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bontempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Carafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5374-3527","authenticated-orcid":false,"given":"Angela","family":"Nebbioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"issue":"3","key":"4440_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.molcel.2018.07.015","volume":"71","author":"SL Campbell","year":"2018","unstructured":"Campbell SL, Wellen KE. Metabolic signaling to the nucleus in cancer. Mol Cell. 2018;71(3):398\u2013408.","journal-title":"Mol Cell"},{"key":"4440_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.972020","volume":"10","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang Y, Li W, Zhou X. Lactylation, an emerging hallmark of metabolic reprogramming: current progress and open challenges. Front Cell Dev Biol. 2022;10: 972020.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"4440_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.tcb.2007.04.001","volume":"17","author":"JN Feige","year":"2007","unstructured":"Feige JN, Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007;17(6):292\u2013301.","journal-title":"Trends Cell Biol"},{"issue":"7","key":"4440_CR4","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","volume":"123","author":"AE Kane","year":"2018","unstructured":"Kane AE, Sinclair DA. Sirtuins and NAD(+) in the development and treatment of metabolic and cardiovascular diseases. Circ Res. 2018;123(7):868\u201385.","journal-title":"Circ Res"},{"key":"4440_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3389\/fphar.2020.01225","volume":"11","author":"C Iside","year":"2020","unstructured":"Iside C, Scafuro M, Nebbioso A, Altucci L. SIRT1 activation by natural phytochemicals: an overview. Front Pharmacol. 2020;11:1225.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4440_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10741-021-10171-0","volume":"27","author":"Z Hajializadeh","year":"2022","unstructured":"Hajializadeh Z, Khaksari M. The protective effects of 17-\u03b2 estradiol and SIRT1 against cardiac hypertrophy: a review. Heart Fail Rev. 2022;27(2):725\u201338.","journal-title":"Heart Fail Rev"},{"key":"4440_CR7","doi-asserted-by":"publisher","first-page":"1111320","DOI":"10.3389\/fphar.2023.1111320","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhao R, Wu C, Liang X, He L, Wang L, et al. Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling. Front Pharmacol. 2023;14:1111320.","journal-title":"Front Pharmacol"},{"issue":"9","key":"4440_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.31083\/j.fbl2709253","volume":"27","author":"Z Nemeth","year":"2022","unstructured":"Nemeth Z, Kiss E, Takacs I. The role of epigenetic regulator SIRT1 in balancing the homeostasis and preventing the formation of specific \u201csoil\u201d of metabolic disorders and related cancers. Front Biosci (Landmark Ed). 2022;27(9):253.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"4440_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2021.129952","volume":"1865","author":"LM Garcia-Peterson","year":"2021","unstructured":"Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj. 2021;1865(9): 129952.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"1","key":"4440_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/med.21436","volume":"38","author":"M Schiedel","year":"2018","unstructured":"Schiedel M, Robaa D, Rumpf T, Sippl W, Jung M. The current state of NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets. Med Res Rev. 2018;38(1):147\u2013200.","journal-title":"Med Res Rev"},{"key":"4440_CR11","doi-asserted-by":"publisher","first-page":"6782872","DOI":"10.1155\/2020\/6782872","volume":"2020","author":"F Jiao","year":"2020","unstructured":"Jiao F, Gong Z. The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longev. 2020;2020:6782872.","journal-title":"Oxid Med Cell Longev"},{"issue":"2","key":"4440_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41419-020-2308-4","volume":"11","author":"Y An","year":"2020","unstructured":"An Y, Wang B, Wang X, Dong G, Jia J, Yang Q. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK\/FOXO3 positive feedback loop. Cell Death Dis. 2020;11(2):115.","journal-title":"Cell Death Dis"},{"issue":"4","key":"4440_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12690","volume":"69","author":"D Xu","year":"2020","unstructured":"Xu D, Liu L, Zhao Y, Yang L, Cheng J, Hua R, et al. Melatonin protects mouse testes from palmitic acid-induced lipotoxicity by attenuating oxidative stress and DNA damage in a SIRT1dependent manner. J Pineal Res. 2020;69(4): e12690.","journal-title":"J Pineal Res"},{"issue":"5","key":"4440_CR14","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1007\/s10753-021-01457-4","volume":"44","author":"S Ubaid","year":"2021","unstructured":"Ubaid S, Rumman M, Singh B, Pandey S. Correction to: role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation. 2021;44(5):2142.","journal-title":"Inflammation"},{"issue":"5","key":"4440_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrendo.2011.225","volume":"8","author":"A Chalkiadaki","year":"2012","unstructured":"Chalkiadaki A, Guarente L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat Rev Endocrinol. 2012;8(5):287\u201396.","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"4440_CR16","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.molcel.2015.10.037","volume":"60","author":"C Chang","year":"2015","unstructured":"Chang C, Su H, Zhang D, Wang Y, Shen Q, Liu B, et al. AMPK-dependent phosphorylation of GAPDH triggers Sirt1 activation and is necessary for autophagy upon glucose starvation. Mol Cell. 2015;60(6):930\u201340.","journal-title":"Mol Cell"},{"issue":"2","key":"4440_CR17","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/j.gastro.2013.10.059","volume":"146","author":"Y Li","year":"2014","unstructured":"Li Y, Wong K, Giles A, Jiang J, Lee JW, Adams AC, et al. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21. Gastroenterology. 2014;146(2):539-49.e7.","journal-title":"Gastroenterology."},{"issue":"2","key":"4440_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL. Sirt1 and the mitochondria. Mol Cells. 2016;39(2):87\u201395.","journal-title":"Mol Cells"},{"issue":"2","key":"4440_CR19","first-page":"198","volume":"9","author":"F Bost","year":"2019","unstructured":"Bost F, Kaminski L. The metabolic modulator PGC-1\u03b1 in cancer. Am J Cancer Res. 2019;9(2):198\u2013211.","journal-title":"Am J Cancer Res"},{"issue":"3","key":"4440_CR20","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c10836","volume":"143","author":"Q Huang","year":"2021","unstructured":"Huang Q, Su H, Qi B, Wang Y, Yan K, Wang X, et al. A SIRT1 activator, ginsenoside rc, promotes energy metabolism in cardiomyocytes and neurons. J Am Chem Soc. 2021;143(3): 141627.","journal-title":"J Am Chem Soc"},{"issue":"6\u20137","key":"4440_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1080\/15592294.2019.1704349","volume":"15","author":"L Scisciola","year":"2020","unstructured":"Scisciola L, Sarno F, Carafa V, Cosconati S, Di Maro S, Ciuffreda L, et al. Two novel SIRT1 activators, SCIC2 and SCIC21, enhance SIRT1-mediated effects in stress response and senescence. Epigenetics. 2020;15(6\u20137):664\u201383.","journal-title":"Epigenetics."},{"issue":"8","key":"4440_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00018-022-04429-5","volume":"79","author":"A Carrizzo","year":"2022","unstructured":"Carrizzo A, Iside C, Nebbioso A, Carafa V, Damato A, Sciarretta S, et al. SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency. Cell Mol Life Sci. 2022;79(8):410.","journal-title":"Cell Mol Life Sci"},{"key":"4440_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2022.101561","volume":"64","author":"U Chianese","year":"2022","unstructured":"Chianese U, Papulino C, Passaro E, Evers TM, Babaei M, Toraldo A, et al. Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics. Mol Metab. 2022;64: 101561.","journal-title":"Mol Metab"},{"key":"4440_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/srep00150","volume":"1","author":"HS Ghosh","year":"2011","unstructured":"Ghosh HS, Reizis B, Robbins PD. SIRT1 associates with eIF2-alpha and regulates the cellular stress response. Sci Rep. 2011;1:150.","journal-title":"Sci Rep"},{"issue":"8","key":"4440_CR25","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1101\/gad.188482.112","volume":"26","author":"J Yuan","year":"2012","unstructured":"Yuan J, Luo K, Liu T, Lou Z. Regulation of SIRT1 activity by genotoxic stress. Genes Dev. 2012;26(8):791\u20136.","journal-title":"Genes Dev"},{"issue":"1","key":"4440_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2013-11-538819","volume":"124","author":"D Sasca","year":"2014","unstructured":"Sasca D, H\u00e4hnel PS, Szybinski J, Khawaja K, Kriege O, Pante SV, et al. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood. 2014;124(1):121\u201333.","journal-title":"Blood"},{"issue":"6","key":"4440_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cmet.2016.06.001","volume":"23","author":"VD Longo","year":"2016","unstructured":"Longo VD, Panda S. Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab. 2016;23(6):1048\u201359.","journal-title":"Cell Metab"},{"issue":"7","key":"4440_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7150\/ijbs.19370","volume":"13","author":"RB Ding","year":"2017","unstructured":"Ding RB, Bao J, Deng CX. Emerging roles of SIRT1 in fatty liver diseases. Int J Biol Sci. 2017;13(7):852\u201367.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"4440_CR29","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2006.11.013","volume":"127","author":"M Lagouge","year":"2006","unstructured":"Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006;127(6):1109\u201322.","journal-title":"Cell"},{"key":"4440_CR30","doi-asserted-by":"publisher","first-page":"e70672","DOI":"10.7554\/eLife.70672","volume":"10","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhong T, Li Y, Li X, Yuan X, Liu L, et al. The hepatic AMPK-TET1-SIRT1 axis regulates glucose homeostasis. Elife. 2021;10:e70672.","journal-title":"Elife."},{"issue":"1","key":"4440_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.apsb.2020.06.016","volume":"11","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Fan X, Jiao T, Li W, Chen P, Jiang Y, et al. SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation. Acta Pharm Sin B. 2021;11(1):89\u201399.","journal-title":"Acta Pharm Sin B"},{"key":"4440_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.821317","volume":"9","author":"Z Guo","year":"2022","unstructured":"Guo Z, Fan D, Liu FY, Ma SQ, An P, Yang D, et al. NEU1 regulates mitochondrial energy metabolism and oxidative stress post-myocardial infarction in mice via the SIRT1\/PGC-1 alpha axis. Front Cardiovasc Med. 2022;9: 821317.","journal-title":"Front Cardiovasc Med"},{"key":"4440_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/B978-0-12-407766-9.00016-X","volume":"91","author":"JK Kemper","year":"2013","unstructured":"Kemper JK, Choi SE, Kim DH. Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism. Vitam Horm. 2013;91:385\u2013404.","journal-title":"Vitam Horm"},{"key":"4440_CR34","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/msb.2012.20","volume":"8","author":"NA Graham","year":"2012","unstructured":"Graham NA, Tahmasian M, Kohli B, Komisopoulou E, Zhu M, Vivanco I, et al. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Mol Syst Biol. 2012;8:589.","journal-title":"Mol Syst Biol"},{"issue":"2","key":"4440_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","volume":"154","author":"L Mouchiroud","year":"2013","unstructured":"Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cant\u00f3 C, et al. The NAD(+)\/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell. 2013;154(2):430\u201341.","journal-title":"Cell"},{"key":"4440_CR36","doi-asserted-by":"publisher","first-page":"5567174","DOI":"10.1155\/2022\/5567174","volume":"2022","author":"L Zhang","year":"2022","unstructured":"Zhang L, Du Z, He L, Liang W, Liu K, Gong S. ROS-induced oxidative damage and mitochondrial dysfunction mediated by inhibition of SIRT3 in cultured cochlear cells. Neural Plast. 2022;2022:5567174.","journal-title":"Neural Plast"},{"issue":"4","key":"4440_CR37","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/toxres\/tfac043","volume":"11","author":"M Li","year":"2022","unstructured":"Li M, Cai Y, Chen X, Zhang L, Jiang Z, Yu Q. Tamoxifen induced hepatic steatosis in highfat feeding rats through SIRT1-Foxo1 suppression and LXR-SREBP1c activation. Toxicol Res (Camb). 2022;11(4):673\u201382.","journal-title":"Toxicol Res (Camb)"},{"issue":"6","key":"4440_CR38","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.molcel.2012.09.030","volume":"48","author":"JE Dominy Jr","year":"2012","unstructured":"Dominy JE Jr, Lee Y, Jedrychowski MP, Chim H, Jurczak MJ, Camporez JP, et al. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol Cell. 2012;48(6):900\u201313.","journal-title":"Mol Cell"},{"issue":"29","key":"4440_CR39","doi-asserted-by":"publisher","first-page":"10684","DOI":"10.1073\/pnas.1411026111","volume":"111","author":"P Zhang","year":"2014","unstructured":"Zhang P, Tu B, Wang H, Cao Z, Tang M, Zhang C, et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion. Proc Natl Acad Sci USA. 2014;111(29):10684\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"4440_CR40","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ana.22236","volume":"69","author":"P Wang","year":"2011","unstructured":"Wang P, Xu TY, Guan YF, Tian WW, Viollet B, Rui YC, et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol. 2011;69(2):360\u201374.","journal-title":"Ann Neurol"},{"issue":"12","key":"4440_CR41","doi-asserted-by":"publisher","first-page":"74866","DOI":"10.1038\/s41575-019-0217-8","volume":"16","author":"L Satriano","year":"2019","unstructured":"Satriano L, Lewinska M, Rodrigues PM, Banales JM, Andersen JB. Metabolic rearrangements in primary liver cancers: cause and consequences. Nat Rev Gastroenterol Hepatol. 2019;16(12):74866.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4440_CR42","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1186\/1471-2407-14-978","volume":"14","author":"C Hao","year":"2014","unstructured":"Hao C, Zhu PX, Yang X, Han ZP, Jiang JH, Zong C, et al. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma. BMC Cancer. 2014;14:978.","journal-title":"BMC Cancer"},{"issue":"20","key":"4440_CR43","doi-asserted-by":"publisher","first-page":"29255","DOI":"10.18632\/oncotarget.8711","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Xu S, Li J, Zheng L, Feng M, Wang X, et al. SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1\u03b1-mediated mitochondrial biogenesis. Oncotarget. 2016;7(20):29255\u201374.","journal-title":"Oncotarget"},{"issue":"4","key":"4440_CR44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.celrep.2017.04.004","volume":"19","author":"E Limagne","year":"2017","unstructured":"Limagne E, Thibaudin M, Euvrard R, Berger H, Chalons P, V\u00e9gan F, et al. Sirtuin-1 activation controls tumor growth by impeding Th17 differentiation via STAT3 deacetylation. Cell Rep. 2017;19(4):746\u201359.","journal-title":"Cell Rep"},{"issue":"10","key":"4440_CR45","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1158\/1078-0432.CCR-15-1760","volume":"22","author":"CC Chini","year":"2016","unstructured":"Chini CC, Espindola-Netto JM, Mondal G, Guerrico AM, Nin V, Escande C, et al. SIRT1 activating compounds (STAC) negatively regulate pancreatic cancer cell growth and viability through a SIRT1 lysosomal-dependent pathway. Clin Cancer Res. 2016;22(10):2496\u2013507.","journal-title":"Clin Cancer Res"},{"key":"4440_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.arr.2018.02.004","volume":"43","author":"ALC Ong","year":"2018","unstructured":"Ong ALC, Ramasamy TS. Role of sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming. Ageing Res Rev. 2018;43:64\u201380.","journal-title":"Ageing Res Rev"},{"issue":"Pt 1","key":"4440_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1113\/jphysiol.2006.108506","volume":"574","author":"B Viollet","year":"2006","unstructured":"Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, et al. Activation of AMPactivated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol. 2006;574(Pt 1):41\u201353.","journal-title":"J Physiol"},{"key":"4440_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ebiom.2017.03.019","volume":"18","author":"SJ Park","year":"2017","unstructured":"Park SJ, Ahmad F, Um JH, Brown AL, Xu X, Kang H, et al. Specific Sirt1 activator-mediated improvement in glucose homeostasis requires sirt1-independent activation of AMPK. EBioMedicine. 2017;18:128\u201338.","journal-title":"EBioMedicine."},{"issue":"3215","key":"4440_CR49","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O. On respiratory impairment in cancer cells. Science. 1956;124(3215):269\u201370.","journal-title":"Science"},{"issue":"1","key":"4440_CR50","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Li J, Zhao G, Huang KC, Cardenas H, Wang Y, et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13(1):4554.","journal-title":"Nat Commun"},{"issue":"6","key":"4440_CR51","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (review). Oncol Lett. 2012;4(6):1151\u20137.","journal-title":"Oncol Lett"},{"issue":"1","key":"4440_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cells8010011","volume":"8","author":"SB Song","year":"2018","unstructured":"Song SB, Hwang ES. A rise in ATP, ROS, and mitochondrial content upon glucose withdrawal correlates with a dysregulated mitochondria turnover mediated by the activation of the protein deacetylase SIRT1. Cells. 2018;8(1):11.","journal-title":"Cells."},{"issue":"6","key":"4440_CR53","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.cmet.2010.11.015","volume":"12","author":"X Qiu","year":"2010","unstructured":"Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010;12(6):662\u20137.","journal-title":"Cell Metab"},{"issue":"1","key":"4440_CR54","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.18632\/oncotarget.12157","volume":"8","author":"X Ye","year":"2017","unstructured":"Ye X, Li M, Hou T, Gao T, Zhu WG, Yang Y. Sirtuins in glucose and lipid metabolism. Oncotarget. 2017;8(1):1845\u201359.","journal-title":"Oncotarget"},{"issue":"13","key":"4440_CR55","doi-asserted-by":"publisher","first-page":"R569","DOI":"10.1016\/j.cub.2015.05.012","volume":"25","author":"NJ German","year":"2015","unstructured":"German NJ, Haigis MC. Sirtuins and the metabolic hurdles in cancer. Curr Biol. 2015;25(13):R569\u201383.","journal-title":"Curr Biol"},{"key":"4440_CR56","doi-asserted-by":"publisher","first-page":"7196280","DOI":"10.1155\/2016\/7196280","volume":"2016","author":"L Faloppi","year":"2016","unstructured":"Faloppi L, Bianconi M, Memeo R, Casadei Gardini A, Giampieri R, Bittoni A, et al. Lactate dehydrogenase in hepatocellular carcinoma: something old something new. Biomed Res Int. 2016;2016:7196280.","journal-title":"Biomed Res Int"},{"issue":"4","key":"4440_CR57","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.molcel.2011.08.044","volume":"44","author":"N Sen","year":"2011","unstructured":"Sen N, Satija YK, Das S. PGC-1\u03b1, a key modulator of p53, promotes cell survival upon metabolic stress. Mol Cell. 2011;44(4):621\u201334.","journal-title":"Mol Cell"},{"issue":"8","key":"4440_CR58","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1101\/gad.275891.115","volume":"30","author":"M Jennis","year":"2016","unstructured":"Jennis M, Kung CP, Basu S, Budina-Kolomets A, Leu JI, Khaku S, et al. An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model. Genes Dev. 2016;30(8):918\u201330.","journal-title":"Genes Dev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04440-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04440-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:32:13Z","timestamp":1700476333000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04440-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4440"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04440-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3023425\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"5 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.N. and L.A. are holders of European Patent Application no.20744080.1\u20131118, relating to SIRT activators and their use, filed on 27 September 2022 and sponsored by Epi-C srl. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"627"}}